Matt Hermann
Senior Managing Director @ Ascension Ventures
St Louis, United States
Matt Hermann is a Series C investor at Ascension Ventures in St Louis focused on Big Data and Health Care. Matt Hermann actively leads AHV's overall investing efforts. Matt has held board member or observer roles at several AHV portfolio companies, including BioImagene, BodyMedia, Millennium Pharmacy Systems, and ZONARE. He also serves on the board of BioEnterprise (www.bioenterprise.com). Before joining AHV in 2001, he served as vice presidentwith Atlantic Medical Management, LLC, a New York-based venture capital management company focused on early- to mid-stage healthcare services and information technology investments. Prior to that, Matt served in financial management roles at two publicly traded healthcare companies, Nutrition 21, Inc. and Regeneron Pharmaceuticals, Inc., and worked at J.P. Morgan Chase & Co. and PricewaterhouseCoopers in New York City. He holds a BS in Engineering from Tufts University, and an MBA in Finance from New York University, Leonard N. Stern Graduate School of Business. In his free time, Matt enjoys participating in sports like basketball and tennis, spending time with his family, and eating at restaurants with amazing food at reasonable prices.
- Total investments:
- 1
- Last investment:
- Lead investor:
- 100%
Last updated:
For AI agents: llms.txt
Industries Matt Hermann invests in
Stages Matt Hermann invests in
Countries Matt Hermann invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Big Data 1 (100%)
- Health Care 1 (100%)
- Bioinformatics 1 (100%)
- Cloud Computing 1 (100%)
- Precision Medicine 1 (100%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| To achieve more precise care for every patient, we need to transform real-world evidence into insights that can directly impact care. At Syapse, that is real-world care. It’s found in the way we empower healthcare organizations to work together in active, transparent partnerships, delivering complete patient insights to answer the questions thatmatter and then purposefully applying it at where patients receive care – driving real impact for cancer patients and beyond. | $25M / Series C / Jan 12, 2016 |
Co-Investors
About Ascension Ventures
AHV was established in 2001 by Ascension Health with a commitment of $125 million to invest in expansion- to late-stage healthcare companies. Ascension Health is the nation's largest Catholic and largest nonprofit health system serving patients through a network of hospitals and health facilities in 20 states and the District of Columbia. AHV offers its limited partners the ability to earn venture-level financial returns while providing early insight to future healthcare developments.
Ascension Ventures Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Brendan Salvino
Senior Associate
|
|||
Brian Belsky
Principal
|
|||
Jamie Wehrung
Chief Administrative Officer
|
|||
John Kuelper
Co-Founder & CEO; Managing Director
|
|||
|
Matt Hermann
Senior Managing Director
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Matt Hermann invest in?
Matt Hermann invests primarily in Big Data, Health Care and Bioinformatics startups, most often at Series C stage. Most of the 1 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Matt Hermann?
Public channels for Matt Hermann include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Matt Hermann last invest?
The most recent investment recorded for Matt Hermann closed in Jan 2016. Shizune tracks 1 investment in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
